$2.47T
Total marketcap
$201.59B
Total volume
BTC 50.21%     ETH 15.64%
Dominance

Roivant Sciences ROIV Stock

9.87 USD {{ price }} -2.662726% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
7.95B USD
LOW - HIGH [24H]
9.85 - 10.2 USD
VOLUME [24H]
5.14M USD
{{ volume }}
P/E Ratio
1.87
Earnings per share
5.27 USD

Roivant Sciences Price Chart

Roivant Sciences ROIV Financial and Trading Overview

Roivant Sciences stock price 9.87 USD
Previous Close 9.71 USD
Open 9.63 USD
Bid 0 USD x 1000
Ask 0 USD x 1400
Day's Range 9.53 - 9.93 USD
52 Week Range 2.87 - 10.12 USD
Volume 1.71M USD
Avg. Volume 3.23M USD
Market Cap 7.52B USD
Beta (5Y Monthly) 1.217524
PE Ratio (TTM) N/A
EPS (TTM) 5.27 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 13.56 USD

ROIV Valuation Measures

Enterprise Value 7.03B USD
Trailing P/E N/A
Forward P/E -7.4586463
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 174.4521
Price/Book (mrq) 7.543726
Enterprise Value/Revenue 163.026
Enterprise Value/EBITDA N/A

Trading Information

Roivant Sciences Stock Price History

Beta (5Y Monthly) 1.217524
52-Week Change 126.48%
S&P500 52-Week Change 20.43%
52 Week High 10.12 USD
52 Week Low 2.87 USD
50-Day Moving Average 8.86 USD
200-Day Moving Average 6.98 USD

ROIV Share Statistics

Avg. Volume (3 month) 3.23M USD
Avg. Daily Volume (10-Days) 3.14M USD
Shares Outstanding 758.43M
Float 207.81M
Short Ratio 5.23
% Held by Insiders 34.87%
% Held by Institutions 53.39%
Shares Short 14.16M
Short % of Float 8.79%
Short % of Shares Outstanding 1.87%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End March 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -2517.65%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -27.13%
Return on Equity (ttm) -72.81%

Income Statement

Revenue (ttm) 43.13M USD
Revenue Per Share (ttm) 0.06 USD
Quarterly Revenue Growth (yoy) -29.89%
Gross Profit (ttm) -413815000 USD
EBITDA N/A
Net Income Avi to Common (ttm) -1245474944 USD
Diluted EPS (ttm) -1.83
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.53B USD
Total Cash Per Share (mrq) 2.01 USD
Total Debt (mrq) 479.64M USD
Total Debt/Equity (mrq) 33.61 USD
Current Ratio (mrq) 6.74
Book Value Per Share (mrq) 1.315

Cash Flow Statement

Operating Cash Flow (ttm) -811774016 USD
Levered Free Cash Flow (ttm) -571135616 USD

Profile of Roivant Sciences

Country United States
State N/A
City London
Address 50 Broadway
ZIP SW1H 0DB
Phone 44 20 7400 3347
Website https://roivant.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 863

Roivant Sciences Ltd. focuses on discovery, development, and commercialization of medicines. It develops transformative medicines by building technologies and developing talent in creative ways, leveraging its platform to launch Vants – nimble and focuses biopharmaceutical and health technology companies. The company was founded in 2014 and is based in London, the United Kingdom.

Q&A For Roivant Sciences Stock

What is a current ROIV stock price?

Roivant Sciences ROIV stock price today per share is 9.87 USD.

How to purchase Roivant Sciences stock?

You can buy ROIV shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Roivant Sciences?

The stock symbol or ticker of Roivant Sciences is ROIV.

Which industry does the Roivant Sciences company belong to?

The Roivant Sciences industry is Biotechnology.

How many shares does Roivant Sciences have in circulation?

The max supply of Roivant Sciences shares is 805.85M.

What is Roivant Sciences Price to Earnings Ratio (PE Ratio)?

Roivant Sciences PE Ratio is 1.87286530 now.

What was Roivant Sciences earnings per share over the trailing 12 months (TTM)?

Roivant Sciences EPS is 5.27 USD over the trailing 12 months.

Which sector does the Roivant Sciences company belong to?

The Roivant Sciences sector is Healthcare.

Roivant Sciences ROIV included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
Nasdaq US Smart Pharmaceuticals NQSSPH 1454.2 USD
-0.47
1453.71 USD 1464.83 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2568.29 USD
+0.16
2566.7 USD 2581.47 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2078.81 USD
-0.4
2075.76 USD 2093.28 USD
NASDAQ Global Market Composite NQGM 2185.85 USD
-0.31
2177.48 USD 2204.21 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD